Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma von Pullarkat, Vinod A, Lacayo, Norman J, Jabbour, Elias, Rubnitz, Jeffrey E, Bajel, Ashish, Laetsch, Theodore W, Leonard, Jessica, Colace, Susan I, Khaw, Seong Lin, Fleming, Shaun A, Mattison, Ryan J, Norris, Robin, Opferman, Joseph T, Roberts, Kathryn G, Zhao, Yaqi, Qu, Chunxu, Badawi, Mohamed, Schmidt, Michelle, Tong, Bo, Pesko, John C, Sun, Yan, Ross, Jeremy A, Vishwamitra, Deeksha, Rosenwinkel, Lindsey, Kim, Su Young, Jacobson, Amanda, Mullighan, Charles G, Alexander, Thomas B, Stock, Wendy

Volltext

Animate monitoring is not uniform: implications for the animate monitoring hypothesis von Loucks, Jeff, Reise, Berit, Gahite, Rosselle, Fleming, Shaun

Volltext

The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice von Turner, Rose, Kalff, Anna, Bergin, Krystal, Gorniak, Malgorzata, Fleming, Shaun, Spencer, Andrew

Volltext

Climate Anxiety: Current Evidence and Future Directions von Boehme, Blake A. E., Kinsman, Laura M., Norrie, Holden J., Tessier, Eric D., Fleming, Shaun W., Asmundson, Gordon J. G.

Volltext

CD34 Chimerism Directed Donor Lymphocyte Infusion With or Without Azacitidine Results in Reduced Relapse and Superior Overall Survival When Full Donor Chimerism is Achieved in Allo... von Tan, Joanne LC, Curtis, David J, Muirhead, Jenny, Swain, Michael I, Fleming, Shaun A, Cirone, Bianca, O'Brien, Maureen E, Wong, Shu M, Inam, Shafqat, Patil, Sushrut, Spencer, Andrew

Volltext

Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 von LING, Silvia C. W, LAU, Edwin K. K, JOSHUA, Douglas E, ALLEN, John D, AL-SHABEEB, Ammira, NIKOLIC, Angela, CATALANO, Albert, ILAND, Harry, HORVATH, Noemi, JOY HO, P, HARRISON, Simon, FLEMING, Shaun

Volltext

Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab von Jabbour, Elias J., Kantarjian, Hagop M., Goekbuget, Nicola, Shah, Bijal D., Chiaretti, Sabina, Park, Jae H., Rijneveld, Anita W., Gore, Lia, Fleming, Shaun, Logan, Aaron C., Ribera, Josep M., Menne, Tobias F., Mezzi, Khalid, Zaman, Faraz, Velasco, Kelly, Boissel, Nicolas

Volltext

Final Analysis of the Phase 1b Chemotherapy And Venetoclax in Elderly Acute Myeloid Leukaemia Trial (CAVEAT) von Chua, Chong Chyn, Loo, Sun, Fong, Chun Yew, Ting, Stephen B, Tiong, Ing S, Fleming, Shaun A, Anstee, Natasha S, Ivey, Adam, Ashby, Michael, Teh, Tse-Chieh, Reynolds, John, Roberts, Andrew W, Wei, Andrew H

Volltext

High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia von Marquis, Miriam, Beaubois, Cyrielle, Lavallée, Vincent-Philippe, Abrahamowicz, Michal, Danieli, Coraline, Lemieux, Sébastien, Ahmad, Imran, Wei, Andrew, Ting, Stephen B., Fleming, Shaun, Schwarer, Anthony, Grimwade, David, Grey, William, Hills, Robert K., Vyas, Paresh, Russell, Nigel, Sauvageau, Guy, Hébert, Josée

Volltext

ALLG APML5: Bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL von Iland, Harry J, Reynolds, John, Boddy, Alan, Schultz, Hayley B, Khoo, Liane, Fleming, Shaun A, Lane, Steven W, Weber, Nicholas, Gasiorowski, Robin, Armytage, Tasman, Harrup, Rosemary Anne, Watson, Anne-Marie, Tan, Peter, Filshie, Robin, Kwok, Fiona, Stevenson, William S, Yuen, Sam L S, Ng, Ashley Peng Chee, Rowley, Leesa, Marlton, Paula, Wei, Andrew H

Volltext

Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysp... von Das, Tongted P., North, Daniel, Fleming, Shaun A., Tan, Joanne L.C., Ivey, Adam, Cummings, Nicholas J., Spencer, Andrew, Patil, Sushrut S., Widjaja, Jacqueline M.L., Swain, Michael I., Bourke, Catherine, O'Brien, Maureen E., Kliman, David S., Curtis, David J.

Volltext

P567: PHASE 1B OMNIVERSE TRIAL: SAFETY AND TOLERABILITY OF ORAL AZACITIDINE IN COMBINATION WITH VENETOCLAX FOR TREATMENT OF ACUTE MYELOID LEUKEMIA von Fleming, Shaun, Roboz, Gail, T. Fathi, Amir, Y. Zhang, Tian, Wei, Andrew, Carraway, Hetty, Holes, Leanne, Petrlik, Erica, Prebet, Thomas, Lopes De Menezes, Daniel, Bluemmert, Iryna, Sun, Hao, Ravandi, Farhad

Volltext

P365: SEQUENTIAL BLINATUMOMAB WITH REDUCED INTENSITY CHEMOTHERAPY FOR OLDER ADULTS WITH NEWLY DIAGNOSED PH‐ B‐PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA – FINAL RESULTS OF THE ALLG ALL... von Fleming, Shaun, Reynolds, John, Bajel, Ashish, Venn, Nicola, Kwan, John, Moore, John, Yeung, David, Pati, Nalini, Leahy, Michael, Kollipara, Sushma, Verner, Emma, Berkahn, Leanne, Sutton, Rosemary, Wei, Andrew, Greenwood, Matthew

Volltext

Bortezomib-based antibody depletion for refractory autoimmune hematological diseases von Ratnasingam, Sumita, Walker, Patricia A., Tran, Huy, Kaplan, Zane S., McFadyen, James D., Tran, Huyen, Teh, Tse-Chieh, Fleming, Shaun, Catalano, John V., Chunilal, Sanjeev D., Johnston, Anna, Opat, Stephen S., Shortt, Jake

Volltext

P494: A FIRST‐IN‐HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK‐MYELODYSPLASIA... von Selwyn Stein, Anthony, Jongen‐Lavrencic, Mojca, Garciaz, Sylvain, A Huls, Gerwin, Maiti, Abhishek, Boissel, Nicolas, De Botton, Stephane, Fleming, Shaun, Michel Zwaan, C., C. de Leeuw, David, Desai, Pinkal, Lucia Arellano, Martha, Avigan, David, Langemeijer, Saskia, Jensen, Kyle, Wagenaar, Timothy, MI, Gu, Abbadessa, Giovanni, Bajel, Ashish

Volltext

P537: SAFETY AND TOLERABILITY OF AZD0466 AS MONOTHERAPY FOR PATIENTS WITH ADVANCED HEMATOLOGICAL MALIGNANCIES ‐ PRELIMINARY RESULTS FROM AN ONGOING PHASE I/II TRIAL von Marconi, Giovanni, Arslan, Shukaib, Fleming, Shaun, Curti, Antonio, S Blachly, James, Martinelli, Giovanni, Giovanni Della Porta, Matteo, Bajel, Ashish, Sauer, Tim, Crysandt, Martina, Pigneux, Arnaud, Konopleva, Marina, Marmor, Yotvat, Sharma, Shringi, Elgeioushi, Nairouz, Rowe, Emily, Cheung, Patricia, Jahn, Ekaterina, Saeh, Jamal, Tibes, Raoul, Zumla Cader, Fathima, Jain, Nitin

Volltext

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia von Fox, Lucy C., Cummins, Katherine D., Costello, Ben, Yeung, David, Cleary, Rebecca, Forsyth, Cecily, Tatarczuch, Maciek, Burbury, Kate, Motorna, Olga, Shortt, Jake, Fleming, Shaun, McQuillan, Andrew, Schwarer, Anthony, Harrup, Rosemary, Holmes, Amy, Ratnasingam, Sumita, Chan, Kah-Lok, Hsu, Wei-Hsun, Ashraf, Asma, Putt, Faye, Grigg, Andrew

Volltext

Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy von Chua, Chong Chyn, Roberts, Andrew W, Reynolds, John, Fong, Chun Yew, Ting, Stephen B, Salmon, Jessica M, MacRaild, Sarah, Ivey, Adam, Tiong, Ing Soo, Fleming, Shaun, Brown, Fiona C, Loo, Sun, Majewski, Ian J, Bohlander, Stefan K, Wei, Andrew H

Volltext

TP53 status and impact on AML prognosis within the ELN 2022 risk classification von Fleming, Shaun, Tsai, Xavier Cheng-Hong, Morris, Rhiannon, Hou, Hsin-An, Wei, Andrew H

Volltext

Tandem measurable residual disease assessment by 10-colour multiparameter flow cytometry and quantitative polymerase chain reaction in core-binding factor and NPM1-mutated acute my... von Zhao, Jessie, Gorniak, Malgorzata, Grigoriadis, George, Fleming, Shaun

Volltext